Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial

NCT07269509 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis

Interventions

PROCEDURE: Basic Intratonsillar Immunotherapy (ITIT)
PROCEDURE: Strengthen Intratonsillar Immunotherapy (ITIT)

Sponsor

Renmin Hospital of Wuhan University